业绩快报 华恒生物(688639.SH)2021年归母净利同比增长38.33%至1.67亿元

Zhitongcaijing · 02/22/2022 08:30
业绩快报 华恒生物(688639.SH)2021年归母净利同比增长38.33%至1.67亿元
智通财经APP讯,华恒生物(688639.SH)发布2021年度业绩快报,2021年营业收入9.54亿元,同比增长95.85%。归属于公司股东的净利润1.67亿元,同比增长38.33%。扣除非经常性损益后归属于公司股东的净利润1.5亿元,同比增长55.28%。基本每股收益1.69元/股。
报告期内,公司产品种类进一步丰富,销售规模持续增长致营业总收入大幅增加,归属于母公司所有者的净利润较上年也大幅增加。
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.